Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004039410 | SCV003684763 | uncertain significance | not specified | 2022-01-27 | criteria provided, single submitter | clinical testing | The c.169T>G (p.S57A) alteration is located in exon 4 (coding exon 1) of the ZNF592 gene. This alteration results from a T to G substitution at nucleotide position 169, causing the serine (S) at amino acid position 57 to be replaced by an alanine (A). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Breakthrough Genomics, |
RCV001573386 | SCV005213338 | likely benign | not provided | criteria provided, single submitter | not provided | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001573386 | SCV001799191 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001573386 | SCV001968592 | likely benign | not provided | no assertion criteria provided | clinical testing |